Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Benchmark raises capital in a variety of ways including but not limited to, private placement, series a offering and common stock offering as well.
Yep doesn’t take much to crash em. ??
It been on an uptrend since end of July until the market correction killed it. Up 400% since the beginning of the year.
Why don’t we just go up a tier to QX.
It’s inevitable for any stock to retrace on such a huge pump.
And all the other pos out there right? Look at the market it’s all red. Geez
Our chart looks similar to many others out there on the Nasdaq. This drop has more to with the current market conditions.
Gonna slap it flip it roll her in flower. You know the rest.
Preferred share offering?
More than 1 share
Great I’ll look for your post
Looking forward to it.
Denial....
.012 to .068 . If that’s not holding gains then I don’t know what is. Unless you’re looking at the daily then not a lot of room for flipping
I don’t think so
Not sure what chart you are looking at but since July 30 it’s been up. .055 to .068.
1.5 mil vol today
It’s up 275% from .018
Huh???
.005<<<.012. .012<<<.060. .060<<< .25. See the pattern?
I agree as it would be a disaster for longs
And the price will fall back below a dollar after Nasdaq . If the company needs a1/100 then their not ready to uplist
Would be out of the question to think that CV is manipulating the share price to keep this propped up so they can cash out
All good points
I’m not complaining about the 14 spent. That was a good deal but really doesn’t qualify as aggressive growth. Acquiring a 4, 6, 8 mil pharmacy is aggressive growth with sales realized quickly. Now we’re taking about a huge amount of shares if the current CV deal used to finance this purchase.
No sales just crap letter of intents to sell more share and keep hope alive. Worthless
This certainly need to rise on its own merit. Just haven’t created enough interest. Why? Because the revs, although are quite good, are just not stellar for peeps to notice. Double or even a 25 % increase in revs would do it. Can we find a pharmacy that can do this and pay for it without diluting the s out of this.
I wish the company could provide guidance on future no dilutive funding and explain how they will meet Nasdaq listing requirements without destroying shareholder equity. I suspect these issues may have buyers nervous.
even .08 would be nice.
I’d like to see another bounce here.
No way. Q2 would have to be a blowout coupled with 3 rd and much larger acquisition as well as a non dilutive way to fund it. Can’t sell
shares at a nickel and say we’ve got your back shareholder.
And paid for without diluting.
I agree
Nice pop keeping it in the channel. Enjoying my vacation in Mammoth fishing. I enjoy reading the board. Many true longs here.
M/A bigger fish for aggressive growth
No he’s saying the news is baked in the the SP going forward. Never heard of such a thing.
Haven’t bought in some time. Not happy with this one. Been buying more of my other although not as much upside, I trust the team to deliver on not only company growth but shareholder growth as well. RXMD doesn’t seem to get that. Nasdaq, that’s going to be a terrible thing for shareholders if not done at the right time and price. I’m feeling negative vibes with the uplist. Company is not even close to moving to a higher exchange. I don’t get the short time line (12 months or so) seems too soon. We can’t even get past 7 penny’s and hold it.
How many time is the bottom going to move down
Good place to be